Valuation (26%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -12.35 | -16.22 |
PEG Ratio (TTM) | 0.03 | -1.41 |
P/S Ratio (TTM) | 5,397.92 | 48.82 |
P/B Ratio (TTM) | 2.17 | 21.13 |
P/FCF Ratio (TTM) | -11.38 | 9.38 |
Price to 5YR AVG Earnings Ratio | N/A | -0.21 |
Price to 5YR AVG FCF Ratio | N/A | -7.10 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -16.89% | -3.10% |
ROE (TTM) | -16.39% | 24.21% |
Net Profit Margin (TTM) | -43,707.50% | -1,069.78% |
ROIC 5YR AVG | N/A | 16.50% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -18.71% | -911.91% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -19.01% | -662.19% | N/A |
Cash Flow | -7.11% | -551.18% | N/A |
Health (61%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 19.60 | 5.75 |
Quick Ratio (TTM) | 19.60 | 5.47 |
D/E Ratio (TTM) | 0.00 | -15.13 |
Interest Coverage (TTM) | -114.81 | 3.59 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 30.98 | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | N/A | 118.86% |